Lu DY, Che JY, Lu TR and Ding J
Ebola epidemic was re-outbreak again last year. The medical capabilities against disease spreads or therapeutics need to be boosted. Many targeted therapies are still under investigations and newly licensed in a small scale. This article outlines multiple phases of Ebola epidemics-its origin and therapeutic options and economic conditions in these medications. New ideas and future perspectives are given.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 